Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis--report of four cases

The American Journal of Gastroenterology
D KyriakouG D Eliopoulos

Abstract

Four patients with systemic mastocytosis, two men and two women, are presented. Three of them (patients 1, 2, and 4) developed portal hypertension and ascites without histological evidence of cirrhosis in liver biopsy. The remaining patient (patient 3) had severe bone lesions with multiple vertebral fractures. None of the patients had skin or lymph node involvement. Two patients (patients 1 and 2) died 12 and 9 months after diagnosis with acute nonlymphocytic leukemia and overt mastocytic leukemia, respectively, while the other two (patients 3 and 4) are alive 58 and 14 months after diagnosis. Treatment with hydroxyurea or cytosine arabinoside had not any beneficial effect in two patients, while a substantial amelioration of back pain had been obtained by local irradiation and recombinant human interferon-alpha-2b administration in one patient (patient 3). All patients had laboratory findings compatible with autoimmune cholangitis. We concluded that systemic mastocytosis is a rare cause of noncirrhotic portal hypertension often simulating autoimmune cholangitis and leading to the erroneous diagnosis of liver cirrhosis. Diagnosis is based on the presence of mast cells in Giemsa-stained liver histological sections, and it may be ...Continue Reading

References

Jan 1, 1992·Clinical Neurology and Neurosurgery·C J Frijns, J Troost
Feb 27, 1992·The New England Journal of Medicine·H C Kluin-NelemansR Willemze
Aug 1, 1992·American Journal of Clinical Oncology·N A JanjanG Derfus
Jan 1, 1992·Dermatology : International Journal for Clinical and Investigative Dermatology·B Gasior-Chrzan, E S Falk
Feb 1, 1992·Annals of the Rheumatic Diseases·D J Bac, M van Marwijk Kooy
Feb 27, 1992·The New England Journal of Medicine·K F Austen
Nov 1, 1991·British Journal of Haematology·S DashN Varma
Sep 1, 1991·British Journal of Haematology·A Le TourneauJ Diebold
Dec 1, 1986·Mayo Clinic Proceedings·W D TravisP M Banks
Jun 25, 1987·The New England Journal of Medicine·L B SchwartzT Sullivan
Sep 1, 1988·Gastroenterology·J A ChernerD D Metcalfe
Feb 1, 1983·The Journal of Allergy and Clinical Immunology·J TurkL J Roberts

❮ Previous
Next ❯

Citations

Sep 22, 2001·Clinics in Liver Disease·E Molina, K R Reddy
Nov 25, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Ted M Roth
Jun 30, 2009·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Darrin L WillinghamDavid J Kramer
Nov 4, 2009·Pathology International·Masayuki YoshidaKatsuhiko Enomoto
Dec 18, 2012·Blood·Sophie Georgin-LavialleGandhi Damaj
Aug 22, 2003·British Journal of Haematology·Peter ValentDean D Metcalfe
May 10, 2002·The American Journal of Pathology·Friedrich WimazalPeter Valent
Feb 28, 2002·Journal of Hepatology·Marianna D A GaçaR Christopher Benyon
May 30, 2001·Leukemia Research·P ValentJ M Bennett
Jul 26, 2000·Hematology/oncology Clinics of North America·R T Jensen
Jul 26, 2000·Hematology/oncology Clinics of North America·A S Worobec
Jun 20, 2006·Best Practice & Research. Clinical Haematology·A PardananiP Valent
Oct 1, 2015·Hepatic Oncology·Nina WaldburgerBeate Katharina Straub
Mar 26, 2004·Gastroentérologie Clinique Et Biologique·Dominique WendumJean-François Flejou
Sep 18, 2007·European Journal of Gastroenterology & Hepatology·Sonia S KupferSmruti R Mohanty
Nov 30, 2010·Clinics in Liver Disease·Sanjaya K Satapathy, David Bernstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Archivos de cardiología de México
M A Peña Duque
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J RakR S Kerbel
© 2021 Meta ULC. All rights reserved